HansBiomed Corporation (042520) — Cash Flow Reinvestment Rate
HansBiomed Corporation (042520) has a Cash Flow Reinvestment Rate of 0.37x as of September 2025, reinvesting ₩448.85 Million (capex ₩448.85 Million ) from operating cash flow of ₩1.21 Billion. See HansBiomed Corporation free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HansBiomed Corporation Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for HansBiomed Corporation across 10 annual periods. For the full cash flow conversion analysis, see HansBiomed Corporation cash flow conversion.
Annual Cash Flow Reinvestment Rate for HansBiomed Corporation (2012–2025)
Year-by-year capital reinvestment analysis for HansBiomed Corporation. See HansBiomed Corporation (042520) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 5.58x | ₩1.78 Billion | ₩318.34 Million | ₩1.76 Billion | ▲ +4.2% |
| 2024 | 5.36x | ₩9.42 Billion | ₩1.76 Billion | ₩2.83 Billion | ▲ +127.0% |
| 2020 | 2.36x | ₩13.57 Billion | ₩5.75 Billion | ₩7.05 Billion | ▼ -19.2% |
| 2019 | 2.92x | ₩22.54 Billion | ₩7.71 Billion | ₩15.56 Billion | ▲ +282.6% |
| 2018 | 0.76x | ₩3.97 Billion | ₩5.20 Billion | ₩2.24 Billion | ▼ -67.7% |
| 2017 | 2.37x | ₩13.24 Billion | ₩5.60 Billion | ₩13.05 Billion | ▲ +30.9% |
| 2015 | 1.81x | ₩6.26 Billion | ₩3.47 Billion | ₩6.07 Billion | ▼ -72.1% |
| 2014 | 6.47x | ₩13.35 Billion | ₩2.06 Billion | ₩12.39 Billion | ▲ +107.1% |
| 2013 | 3.13x | ₩7.29 Billion | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩253.56 Million | ₩1.50 Billion | ₩253.56 Million | — |